J Korean Diabetes.
2012 Mar;13(1):39-43. 10.4093/jkd.2012.13.1.39.
Pharmacotherapy for Postprandial Hyperglycemia in Type 2 Diabetes
- Affiliations
-
- 1Division of Endocrinology and Metabolism, Department of Internal Medicine, Korea University College of Medicine, Seoul, Korea. deisy21@naver.com
- KMID: 1436186
- DOI: http://doi.org/10.4093/jkd.2012.13.1.39
Abstract
- A growing body of evidence shows that effective postprandial hyperglycemia management in individuals with type 2 diabetes can reduce the risk of diabetic complications and cardiovascular diseases. Therefore, accurate monitoring and effective intervention for postprandial hyperglycemia is very important in routine clinical practice for type 2 diabetes. Therapeutic modalities for the management of postprandial hyperglycemia include oral antidiabetic drugs (alpha glucosidase inhibitor, meglitinide, dipeptidyl peptidase-IV inhibitor), ultra-short-acting insulin analogues, and incretin mimetics. A detailed understanding of the advantages and disadvantages of various pharmacotherapies and a careful understanding of the underlying physical and social situations of each patient will be of great help to determine the appropriate prescription for postprandial hyperglycemia management.
